183 related articles for article (PubMed ID: 17481556)
1. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.
Tai HH; Tong M; Ding Y
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):203-8. PubMed ID: 17481556
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
[TBL] [Abstract][Full Text] [Related]
3. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Biochem Pharmacol; 2006 Sep; 72(6):701-9. PubMed ID: 16844092
[TBL] [Abstract][Full Text] [Related]
5. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
7. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.
Tong M; Tai HH
Arch Biochem Biophys; 2005 Mar; 435(1):50-5. PubMed ID: 15680906
[TBL] [Abstract][Full Text] [Related]
8. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.
Tai HH; Cho H; Tong M; Ding Y
Curr Pharm Des; 2006; 12(8):955-62. PubMed ID: 16533162
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin catabolic enzymes as tumor suppressors.
Tai HH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
[TBL] [Abstract][Full Text] [Related]
10. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells.
Chi X; Tai HH
Exp Cell Res; 2010 Aug; 316(14):2251-9. PubMed ID: 20632471
[TBL] [Abstract][Full Text] [Related]
12. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
[TBL] [Abstract][Full Text] [Related]
13. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
[TBL] [Abstract][Full Text] [Related]
14. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase.
Yao B; Xu J; Harris RC; Zhang MZ
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F433-9. PubMed ID: 18057186
[TBL] [Abstract][Full Text] [Related]
15. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
16. 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.
Pham H; Eibl G; Vincenti R; Chong B; Tai HH; Slice LW
Mol Carcinog; 2008 Jun; 47(6):466-77. PubMed ID: 18058808
[TBL] [Abstract][Full Text] [Related]
17. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
[TBL] [Abstract][Full Text] [Related]
18. 5-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis.
Miyoshi J; Yajima T; Shimamura K; Matsuoka K; Okamoto S; Higuchi H; Funakoshi S; Takaishi H; Hibi T
Anticancer Res; 2012 Apr; 32(4):1193-202. PubMed ID: 22493349
[TBL] [Abstract][Full Text] [Related]
19. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]